UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.2305-2313

2006

Volltextzugriff (PDF)

Retinoic Acid Stimulation of the Sodium/Iodide Symporter in MCF-7 Breast Cancer Cells Is Meditated by the Insulin Growth Factor-I/Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase Signaling Pathways

The journal of clinical endocrinology and metabolism, 2008-05, Vol.93 (5), p.1884-1892

2008

Volltextzugriff (PDF)

The AKT kinase is activated in multiple myeloma tumor cells

Blood, 2001-11, Vol.98 (9), p.2853-2855

2001

Volltextzugriff (PDF)

Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-κB dependent

Molecular cancer therapeutics, 2004-06, Vol.3 (6), p.727-736

2004

Volltextzugriff (PDF)

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses

Oncogene, 2002-02, Vol.21 (9), p.1391-1400

2002

Volltextzugriff (PDF)

Drug Interactions between the Proteasome Inhibitor Bortezomib and Cytotoxic Chemotherapy, Tumor Necrosis Factor (TNF) α, and TNF-Related Apoptosis-Inducing Ligand in Prostate Cancer

Clinical cancer research, 2003-10, Vol.9 (12), p.4537

2003

Volltextzugriff (PDF)

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-κB-dependent mechanism

Oncogene, 2005-02, Vol.24 (9), p.1563-1570

2005

Volltextzugriff (PDF)

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism

Oncogene, 2005-02, Vol.24 (9), p.1563-1570

2005

Volltextzugriff (PDF)

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF- B-dependent mechanism

Oncogene, 2005-02, Vol.24 (9), p.1563-1570

2005

Volltextzugriff (PDF)

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses

Oncogene, 2002-02, Vol.21 (9), p.1391-1400

2002

Volltextzugriff (PDF)

Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways

The journal of clinical endocrinology and metabolism, 2008-05, Vol.93 (5), p.1884-1892

2008

Volltextzugriff (PDF)

Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-lnduced apoptosis

Cancer research (Chicago, Ill.), 2006, Vol.66 (4), p.2305-2313

2006

Volltextzugriff (PDF)

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis

Blood, 2005-11, Vol.106 (11), p.1582-1582

2005

Volltextzugriff (PDF)

Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent

Molecular cancer therapeutics, 2004-06, Vol.3 (6), p.727-736

2004

Volltextzugriff (PDF)

Drug interactions between the Proteasome inhibitor Bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) a, and TNF-related apoptosis-inducing ligand in prostate cancer

Clinical cancer research, 2003, Vol.9 (12), p.4537-4545

2003

Volltextzugriff (PDF)

Reported actions elderly individuals take when experiencing physical discomfort and their attitude towards health care and health care providers

Olson-Fisher, Myrna C

1988

Volltextzugriff (PDF)

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

Autophagy, 2014-08, Vol.10 (8), p.1359-1368

2014

Volltextzugriff (PDF)

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

PloS one, 2024-01, Vol.19 (1), p.e0291128-e0291128

2024

Volltextzugriff (PDF)

A safety run‐in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

Cancer, 2012-11, Vol.118 (22), p.5601-5607

2012

Volltextzugriff (PDF)

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States

Clinical cancer research, 2010-04, Vol.16 (8), p.2443-2449

2010

Volltextzugriff (PDF)

Clinical trials of R

PloS one, 2024-01, Vol.19 (1), p.e0291128

2024

Volltextzugriff (PDF)

Clinical trials of R- in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

PloS one, 2024-01, Vol.19 (1), p.e0291128

2024

Volltextzugriff (PDF)

Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium

Biological psychiatry (1969), 2018-07, Vol.84 (2), p.138-147

2018

Volltextzugriff (PDF)

Cognition and Political Ideology in Aging

Journal of the American Geriatrics Society (JAGS), 2021-03, Vol.69 (3), p.762-766

2021

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(39)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Humans
(20)
Biological And Medical Sciences
(11)
Male
(9)
Medical Sciences
(9)
Oncology
(9)
Female
(8)
Apoptosis
(7)
Apoptosis - Drug Effects
(6)
Cell Line, Tumor
(6)
Proteins
(6)
Animals
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Adult
(4)
Bortezomib
(4)
Dacarbazine - Therapeutic Use
(4)
Glioblastoma
(4)
Mice
(4)
Nursing
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis

Retinoic Acid Stimulation of the Sodium/Iodide Symporter in MCF-7 Breast Cancer Cells Is Meditated by the Insulin Growth Factor-I/Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase Signaling Pathways

The AKT kinase is activated in multiple myeloma tumor cells

Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-κB dependent

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses

Drug Interactions between the Proteasome Inhibitor Bortezomib and Cytotoxic Chemotherapy, Tumor Necrosis Factor (TNF) α, and TNF-Related Apoptosis-Inducing Ligand in Prostate Cancer

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-κB-dependent mechanism

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF- B-dependent mechanism

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses

Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways

Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-lnduced apoptosis

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis

Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent

Drug interactions between the Proteasome inhibitor Bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) a, and TNF-related apoptosis-inducing ligand in prostate cancer

Reported actions elderly individuals take when experiencing physical discomfort and their attitude towards health care and health care providers

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

A safety run‐in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States

Clinical trials of R

Clinical trials of R- in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium

Cognition and Political Ideology in Aging

Surgical Site Infections, International Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 30 Countries, 2005–2010

Suchergebnisse filtern